<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr48-0004563220928361">
 <label>48</label>
 <mixed-citation publication-type="other">Hoffmann M, Schroeder S, Kleine-Weber H, et al. Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19. 
  <italic>Antimicrob Agents Chemother</italic>. Epub ahead of print 20 April 2020. DOI: 10.1128/AAC.00754-20
 </mixed-citation>
</ref>
